Bioaffinity Technologies Inc (BIAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 1,446 | 1,270 | 1,854 | 2,208 | 2,350 |
| Cost of Goods | 942 | 1,017 | 1,368 | 1,562 | 1,440 |
| Gross Profit | 504 | 253 | 486 | 645 | 910 |
| Operating Expenses | 3,739 | 2,785 | 3,481 | 4,154 | 3,324 |
| Operating Income | -2,293 | -2,516 | -2,627 | -2,947 | -1,974 |
| Interest Expense | 5 | 11 | 16 | 25 | 22 |
| Other Income | -2,750 | -1,506 | -9 | 5 | -3 |
| Pre-tax Income | -5,048 | -4,032 | -2,652 | -2,967 | -1,998 |
| Income Tax | 3 | 29 | 9 | N/A | 3 |
| Net Income Continuous | -5,051 | -4,061 | -2,660 | -2,967 | -2,001 |
| Net Income | $-5,051 | $-4,061 | $-2,660 | $-2,967 | $-2,001 |
| EPS Basic Total Ops | -4.74 | -5.11 | -4.80 | -5.97 | -4.84 |
| EPS Basic Continuous Ops | -4.74 | -5.08 | -4.91 | -6.04 | -4.85 |
| EPS Diluted Total Ops | -4.74 | -5.11 | -4.80 | -5.97 | -4.84 |
| EPS Diluted Continuous Ops | -4.74 | -5.08 | -4.91 | -6.04 | -4.85 |
| EPS Diluted Before Non-Recurring Items | -2.70 | -3.90 | -4.80 | -6.31 | -4.80 |
| EBITDA(a) | $-2,180 | $-2,402 | $-2,473 | $-2,793 | $-1,823 |